Quick Facts TypePeptide Blend (BPC-157 + TB-500) CategoryRecovery / Tissue Repair AdministrationSubcutaneous injection FrequencyDaily (loading) / 3x weekly (maintenance) Typical Dose250500 mcg of each per dose Cycle Length48 weeks Available Sizes5 mg/5 mg (10 mg total) vials Stability21 days after reconstitution Overview What is the BPC-157 / TB-500 Blend
CARNITINE BETAINE Research suggests that increased betaine availability in muscle tissue due to supplementation has an impact on carnitine metabolism
Emerging research suggests that oxidative stressan imbalance between harmful free radicals and the bodys antioxidant defensesmay play a key role in ASD
Make an appointment today to begin your journey toward achieving younger, healthier, and glowing skin
Lillys small-molecule GLP-1 agonist orforglipron (brand Foundayo) also gained FDA approval in April 2026 for weight loss and is expected to launch in 2027, marking a breakthrough as the first non-peptidic GLP-1 pill ( [35] )
Third-party Certificate of Analysis (COA) available Purity testing showing 98% or higher (99%+ preferred) HPLC-MS testing confirming correct amino acid sequence Endotoxin testing below safe thresholds Clear storage and handling instructions provided Established reputation in user communities Third-party testing through Certificates of Analysis provides essential quality verification